NCT02594267 2021-07-27A Dose-Finding Study of Folotyn® (Pralatrexate Injection) Plus CHOP With Peripheral T-Cell Lymphoma (PTCL)Acrotech Biopharma Inc.Phase 1 Completed48 enrolled